Chinese Journal of Modern Operative Surgery 2017, Vol. 21 Issue (1): 22-26 DOI: 10.16260/j.cnki.1009-2188.2017.01.006 |
Clinical Research |
|
|
|
|
|
Clinical Effect on Procedure for Prolapse and Hemorrhoids Combined with Sclerotherapy of Lauromacrogol Injection for Severe Hemorrhoids: 86 Cases Reports |
LEI Qingjun1, ZHANG Yiqiang1, WANG Yi1, HE Xiangdong2
|
1.Department of General Surgery, the First People's Hospital of Taicang,Taicang 215400, Jiangsu, China; 2.Department of Colorectal Surgery,Traditional Chinese Hospital of Xi'an,Xi'an 710021, Shaanxi, China |
|
|
Abstract ObjectiveTo explore the clinical efficacy of procedure for prolapse and hemorrhoids (PPH) combined with sclerotherapy of lauromacrogol injection for treatment of severe hemorrhoids.MethodsA total of 170 cases with severe hemorrhoids (Ⅲ or Ⅳ stage) were randomized into two groups: The treatment group (n=86) were treated by PPH combined with sclerotherapy lauromacrogol injection, and the control group (n=84) were performed the MilliganMorgan haemorrhoidectomy combined with sclerotherapy of lauromacrogol injection. The perioperative outcomes, clinical effect and postoperative complication were compared between two groups.ResultsThe average operative duration and hospital stays was (23.25±3.41)min and (5.20±0.94)d respectively in the treatment group, and was (60.11±4.85)min and (12.57±1.52)d respectively in the control group. There was statistical difference in operative duration and hospital stays between two groups, the treatment group was better (P<0.05). The total result revealed the effective rate of the treatment group was 95.3% and 96.5% in prolapse symptom and hemorrhage symptom, both were higher than 85.7% and 88.1% of the control group (P<0.05). The postoperative complication of anal pain, analedge edema and dysuria was less in the treatment group than those in the control group (P<0.05), but there was no statistical difference in abnormal defecation between two groups (P>0.05). No anal stenosis was found during followup in both groups.ConclusionThe treatment of PPH combined with sclerotherapy of lauromacrogol injection is an effective therapy for severe hemorrhoids with less damage of the anal function, reliable effect and simple operating.
|
Published: 25 May 2018
|
|
|
|
[1] |
龙晨蒙, 陈龙, 李锋. PPH术与传统痔切除术临床疗效对比分析[J]. 结直肠肛门外科, 2011, 17(3): 149151.
|
[2] |
杨汉元. 痔疮术后护理及常见并发症的观察与处理[J]. 海南医学, 2011, 22(9):143144.
|
[3] |
Onur Gülseren M, Dinc T, zer V, et al. Randomized Controlled Trial Comparing the Effects of Vessel Sealing Device and MilliganMorgan Technique on Postoperative Pain Perception after Hemorrhoidectomy[J]. Dig Surg, 2015, 32(4):258261. doi: 10.1159/000381754.
|
[4] |
Thomson WH. The nature of haemorrhoids[J]. Br J Surg, 1975, 62(7):542552.
|
[5] |
Pescatori M, Gagliardi G. Postoperative complications after procedure for prolapsed hemorrhoids (PPH) and stapled transanal rectal resection (STARR) procedures[J]. Tech Coloproctol, 2008, 12(1):719. doi: 10.1007/s1015100803910.
|
[6] |
Sutherland LM, Burchard AK, Matsuda K, et al. A systematic review of stapled hemorrhoidectomy[J]. Arch Surg, 2002, 137(12):13951406.
|
[7] |
Pernice LM, Bartalucci B, Bencini L, et al. Early and late (ten years) experience with circular stapler hemorrhoidectomy[J]. Dis Colon Rectum, 2001, 44(6):836841.
|
[8] |
Weiss RA, Feied CF, Weiss MA. Vein diagnosis and treatment: a comprehensive approach[M]. New York: McGrawHill Medical Publishing Division, 2000. 304.
|
[9] |
许芙蓉, 余松远. 超声引导穿刺注入聚桂醇治疗子宫内膜异位囊肿的临床研究[J/D]. 中华临床医师杂志:电子版, 2013, 7(14): 67386739.
|
[10] |
Rabe E, Pannier F. Sclerotherapy in venous malformation[J]. Phlebology, 2013, 28 Suppl 1:188191. doi: 10.1177/0268355513477282.
|
[11] |
Agarwal M, Agrawal MS, Mittal R, et al. A randomized study of aspiration and sclerotherapy versus laparoscopic deroofing in management of symptomatic simple renal cysts[J]. J Endourol, 2012, 26(5):561565. doi: 10.1089/end.2011.0559.
|
[12] |
Itou C, Koizumi J, Hashimoto T, et al. Foam sclerotherapy for a symptomatic hepatic cyst: a preliminary report[J]. Cardiovasc Intervent Radiol, 2014, 37(3):800804. doi: 10.1007/s0027001307615.
|
[13] |
郑艳, 徐春丽. 聚桂醇400临床应用进展[J]. 医药导报 2012, 31(2): 190.
|
|
|
|